VEGFA and age-related macular degeneration: Various anti-VEGF (Vascular Endothelial Growth Factor) antibodies are intravitreally administered monthly or bimonthly to patients suffering from the neovascular (wet) form of age-related macular degeneration (wet AMD) [7,8].